US Patent Issued to UNIVERSITEIT GENT, UNIVERSITEIT ANTWERPEN, UNIVERSITAIR ZIEKENHUIS ANTWERPEN on Sept. 23 for "Composition for treatment of vitreous disease or disorder" (Belgian, American, French Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,844, issued on Sept. 23, was assigned to UNIVERSITEIT GENT (Ghent, Belgium), UNIVERSITEIT ANTWERPEN (Antwerp, Belgium) and UNIVERSITAIR ZIEKENHUIS ANTWERPEN (Edegem, Belgium).

"Composition for treatment of vitreous disease or disorder" was invented by Stefaan De Smedt (Mariakerke, Belgium), Felix Sauvage (Roubaix, France), Kevin Braeckmans (Lokeren, Belgium), Katrien Remaut (Ghent, Belgium), Marie-Jose Tassignon (Berchen, Belgium), Juan Fraire (Brussels) and Jerry Sebag (Huntington Beach, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition includes particles for use in a method for the treatment of a vitreous disease or a vitreous d...